Healthcare provider profile · identity verified

Kimberly Ritchie, CNP

Nurse Practitioner · HARRISVILLE, MI · NPI 1356765945

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	255	68
Atorvastatin Calcium	Atorvastatin Calcium	239	70
Simvastatin	Simvastatin	206	51
Lisinopril	Lisinopril	176	50
Rosuvastatin Calcium	Rosuvastatin Calcium	172	50
Omeprazole	Omeprazole	165	52
Losartan Potassium	Losartan Potassium	158	44
Metformin Hcl	Metformin Hcl	153	39
Gabapentin	Gabapentin	133	33
Metoprolol Succinate	Metoprolol Succinate	120	32
Pantoprazole Sodium	Pantoprazole Sodium	105	34
Amlodipine Besylate	Amlodipine Besylate	103	28
Alendronate Sodium	Alendronate Sodium	100	21
Famotidine	Famotidine	87	18
Metoprolol Tartrate	Metoprolol Tartrate	87	26
Furosemide	Furosemide	84	22
Metformin Hcl Er	Metformin Hcl	80	25
Montelukast Sodium	Montelukast Sodium	80	21
Tamsulosin Hcl	Tamsulosin Hcl	76	19
Albuterol Sulfate Hfa	Albuterol Sulfate	75	31
Meloxicam	Meloxicam	72	21
Duloxetine Hcl	Duloxetine Hcl	68	18
Sertraline Hcl	Sertraline Hcl	68	14
Fluticasone Propionate	Fluticasone Propionate	67	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	66	18
Pregabalin	Pregabalin	66	13
Ezetimibe	Ezetimibe	64	18
Amitriptyline Hcl	Amitriptyline Hcl	63	17
Hydrochlorothiazide	Hydrochlorothiazide	62	21
Alprazolam	Alprazolam	61	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	61	18
Carvedilol	Carvedilol	60	15
Trazodone Hcl	Trazodone Hcl	59	16
Eliquis	Apixaban	55	16
Tramadol Hcl	Tramadol Hcl	49	13
Lovastatin	Lovastatin	48	14
Nystatin	Nystatin	48	29
Propranolol Hcl	Propranolol Hcl	47	14
Baclofen	Baclofen	45	24
Buspirone Hcl	Buspirone Hcl	45	13
Fenofibrate	Fenofibrate Nanocrystallized	45	11
Escitalopram Oxalate	Escitalopram Oxalate	43	11
Nitroglycerin	Nitroglycerin	40	21
Trulicity	Dulaglutide	38	suppressed
Clopidogrel	Clopidogrel Bisulfate	37	11
Doxycycline Hyclate	Doxycycline Hyclate	37	26
Fluoxetine Hcl	Fluoxetine Hcl	37	11
Allopurinol	Allopurinol	36	suppressed
Celecoxib	Celecoxib	35	suppressed
Ipratropium Bromide	Ipratropium Bromide	34	24
Citalopram Hbr	Citalopram Hydrobromide	33	11
Potassium Chloride	Potassium Chloride	33	12
Pravastatin Sodium	Pravastatin Sodium	33	suppressed
Finasteride	Finasteride	32	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Ventolin Hfa	Albuterol Sulfate	30	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Farxiga	Dapagliflozin Propanediol	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Fluconazole	Fluconazole	25	16
Valsartan	Valsartan	25	suppressed
Glipizide Er	Glipizide	24	suppressed
Linzess	Linaclotide	24	suppressed
Rybelsus	Semaglutide	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Ozempic	Semaglutide	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	16
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Topiramate	Topiramate	19	suppressed
Methylprednisolone	Methylprednisolone	18	16
Mupirocin	Mupirocin	18	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Gemfibrozil	Gemfibrozil	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Prednisone	Prednisone	15	13
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Lactulose	Lactulose	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	14
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Diazepam	Diazepam	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Nyamyc	Nystatin	12	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Etodolac	Etodolac	11	suppressed
Lubiprostone	Lubiprostone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error